Skip to main content.

Taxpayers spend millions on valley fever in prisons

Fellowship Story Showcase

Taxpayers spend millions on valley fever in prisons

Californians are locked into contributing to the cost of treating state inmates sickened by valley fever. A yearly price tag of $23 million to guard and care for patients in outside hospitals doesn't even take into account what the state prison system racks up treating valley fever within the prison walls. This story is part of the ReportingonHealth Collaborative's "Just One Breath" investigative series on valley fever in California's Central Valley. 

Taxpayers spend millions on valley fever in prisons
Reporting on Health Collaborative
Friday, September 21, 2012

By Rebecca Plevin, Reporting on Health Collaborative

Californians are locked into contributing to the cost of treating state inmates sickened by valley fever.

Since 2006, the state prison system has tried but failed to reduce the disease’s impact and price tag.

California Correctional Health Care Services foots an annual bill of about $23 million for sending inmates with valley fever to hospitals outside the prison, guarding these patients, and for their antifungal treatments. That’s about what it costs to build a new school in Fresno County.

Not included in that sum are the costs the state prison system racks up treating valley fever within the prison walls and the costs attributed to expensive, long-term care for patients with complications of valley fever, such as meningitis.

Effect and Cost on Prison System
Effect and Cost on Prison System

Most of those expenses stem from the high rates of valley fever at eight institutions located in areas of the San Joaquin Valley rife with the fungus that causes the disease. Among those is Pleasant Valley State Prison in Coalinga where, in 2005, the prison’s valley fever rate was 600 times the rate of Fresno County.

That Pleasant Valley outbreak prompted the prison health system to take preventive steps, following recommendations from the California Department of Public Health.

Inmates most vulnerable to the disease – including those with HIV and chronic lung disease requiring oxygen therapy – were sent to prisons outside the region. Inmates were educated about the symptoms of the disease. And plans for new construction at Pleasant Valley State Prison in Coalinga were canceled.

Despite those changes, the rate of valley fever among inmates has continued to climb, mirroring an increase in cases throughout the state. The rate of valley fever at Pleasant Valley dropped from 2006 to 2008, then pitched up sharply through 2010; the rate of disease at Avenal State Prison in Kings County steadily climbed from 2006 to 2010, according to a 2012 report from the prison health care system that found that “additional measures” were needed to stem the rising costs and cases.

Those costs are not confined to the state prison system.

Last month, the U.S. Department of Justice awarded a settlement of $425,000 to Arjang Panah, who contracted valley fever while serving a drug sentence at Taft Correctional Institute in Kern County. “He will require lifetime treatment,” said attorney Ian Wallach, who represented Panah.

Former state Sen. Roy Ashburn (R-Bakersfield) often cited the financial costs of the disease when persuading fellow lawmakers to fund vaccine research. A key component of his argument focused on the prisons: The costs of treating valley fever among inmates and prison guards exceeds the state’s contribution to a cure.

“That’s an issue that made it pretty convincing,” Ashburn said. “On a cost-benefit basis, it made sense to contribute $1 million a year.”

But after Ashburn left office, state lawmakers looking for short-term ways to balance the budget stopped funding the vaccine effort.

Photo credit: iStockphoto.com

About This Series

This project results from an innovative reporting venture – the Center for Health Journalism Collaborative – which currently involves the Bakersfield Californian, Radio Bilingüe in Fresno, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, Hanford Sentinel, the Voice of OC in Santa Ana, the Arizona Daily Star in Tucson, La Estrella de Tucsón and the Center for Health Journalism. The collaborative is an initiative of the Center for Health Journalism at the University of Southern California’s Annenberg School for Communication and Journalism.

RELATED STORIES THIS WEEK

Accurate valley fever counts elude health officials

“Valley fever is almost certainly underreported, due to physicians and the public not being familiar with the disease,” said one infectious disease specialist. Reliable estimates of valley fever cases are still lacking.

CDC technology advances promise better valley fever detection

New sensors in development at the CDC could provide a breakthrough in valley fever detection and prevention throughout the Southwestern United States.

New valley fever skin test shows promise, but obstacles remain

A new skin test called Spherusol can detect whether a person has developed immunity to valley fever. But despite its promise, the test still isn’t in wide use.

FORECASTING AN EPIDEMIC: Does weather hold the key to predicting valley fever outbreaks?

As recently as August, Calif. health officials predicted the number of valley fever cases this year would go down. Now it’s shaping up to be one of the worst years on record.

Public pushes for new thinking in valley fever research

Advocates of valley fever research have complained that the disease does not affect enough people to garner attention and funding; local doctors often misdiagnosed it; most data about the disease dates back decades; and the public has little knowledge of the disease and its impact.

Valley Fever Research Day Aims To Connect With Community

Community members are invited to attend Valley Fever Research Day Saturday at the UCSF Fresno Center for Medical Education and Research. The event is an opportunity for researchers to connect with community members who have been impacted by the fungal disease.

Federal, local officials hopeful for 'new era' in valley fever

Many questions about valley fever remained unanswered Tuesday as public health officials, physicians and politicians finished a two-day symposium on the disease, but many were hopeful that the summit will be a turning point.

Agencies to Launch Randomized Controlled Trial for Valley Fever

Directors of the National Institutes of Health and U.S. Centers for Disease Control and Prevention tell a packed valley fever symposium they are "serious" about finding a better treatment for the disease.